Larimar Therapeutics to Participate in the Guggenheim Virtual Neuro/Immunology Conference Read more about Larimar Therapeutics to Participate in the Guggenheim Virtual Neuro/Immunology Conference Larimar Therapeutics Reports Third Quarter 2021 Operating and Financial Results Read more about Larimar Therapeutics Reports Third Quarter 2021 Operating and Financial Results LifeSci Capital – Patrick Dolezal, M.S Patrick Dolezal, M.S LifeSci Capital JMP Securities - Jonathan Wolleben Jonathan Wolleben JMP Securities William Blair – Myles R. Minter, Ph.D. Myles R. Minter, Ph.D. William Blair Larimar Therapeutics to Participate in SVB Leerink CybeRx Series: Neuromuscular, Rare Diseases & Genetic Medicines Event Read more about Larimar Therapeutics to Participate in SVB Leerink CybeRx Series: Neuromuscular, Rare Diseases & Genetic Medicines Event Larimar Therapeutics to Present at the Morgan Stanley 19th Annual Global Healthcare Conference Read more about Larimar Therapeutics to Present at the Morgan Stanley 19th Annual Global Healthcare Conference Larimar Therapeutics Announces Upcoming Oral Presentation at the World Orphan Drug Congress Read more about Larimar Therapeutics Announces Upcoming Oral Presentation at the World Orphan Drug Congress Larimar Therapeutics Reports Second Quarter 2021 Operating and Financial Results Read more about Larimar Therapeutics Reports Second Quarter 2021 Operating and Financial Results Larimar Therapeutics to Present at the William Blair Biotech Focus Conference 2021 Read more about Larimar Therapeutics to Present at the William Blair Biotech Focus Conference 2021 Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last » Subscribe to
Larimar Therapeutics to Participate in the Guggenheim Virtual Neuro/Immunology Conference Read more about Larimar Therapeutics to Participate in the Guggenheim Virtual Neuro/Immunology Conference
Larimar Therapeutics Reports Third Quarter 2021 Operating and Financial Results Read more about Larimar Therapeutics Reports Third Quarter 2021 Operating and Financial Results
Larimar Therapeutics to Participate in SVB Leerink CybeRx Series: Neuromuscular, Rare Diseases & Genetic Medicines Event Read more about Larimar Therapeutics to Participate in SVB Leerink CybeRx Series: Neuromuscular, Rare Diseases & Genetic Medicines Event
Larimar Therapeutics to Present at the Morgan Stanley 19th Annual Global Healthcare Conference Read more about Larimar Therapeutics to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
Larimar Therapeutics Announces Upcoming Oral Presentation at the World Orphan Drug Congress Read more about Larimar Therapeutics Announces Upcoming Oral Presentation at the World Orphan Drug Congress
Larimar Therapeutics Reports Second Quarter 2021 Operating and Financial Results Read more about Larimar Therapeutics Reports Second Quarter 2021 Operating and Financial Results
Larimar Therapeutics to Present at the William Blair Biotech Focus Conference 2021 Read more about Larimar Therapeutics to Present at the William Blair Biotech Focus Conference 2021